Details for 2019847015
Up to date per 01.04.2026
Actions
Details for 2019847015
Granted/Registered
European Patent
16.06.2021 A
22.11.2023 B1
10.08.2018
US
201862717371 P
A61K 38/16 20060101AFI20230621BHEP
Owner
Alexion Pharmaceuticals, Inc.121 Seaport Blvd Suite 400 Boston, MA 02210US
Representative
No representatives present
Inventor
PETRYK, Anna121 Seaport Blvd, Suite 400 Boston, MA 02210US
Information about Fees